<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-05-27T16:23:28Z</responseDate><request verb="GetRecord" identifier="oai:riuma.uma.es:10630/25713" metadataPrefix="mods">https://riuma.uma.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:riuma.uma.es:10630/25713</identifier><datestamp>2026-02-03T12:28:51Z</datestamp><setSpec>com_10630_2254</setSpec><setSpec>col_10630_37959</setSpec></header><metadata><mods:mods xmlns:doc="http://www.lyncode.com/xoai" xmlns:mods="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
   <mods:name>
      <mods:namePart>Burgos-Molina, Antonio Manuel</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Alamilla Presuel, Juan Carlos</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>González Vidal, Alejandro</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Ruiz-Gómez, Miguel José</mods:namePart>
   </mods:name>
   <mods:extension>
      <mods:dateAvailable encoding="iso8601">2023-01-11T12:46:59Z</mods:dateAvailable>
   </mods:extension>
   <mods:extension>
      <mods:dateAccessioned encoding="iso8601">2023-01-11T12:46:59Z</mods:dateAccessioned>
   </mods:extension>
   <mods:originInfo>
      <mods:dateIssued encoding="iso8601">2022</mods:dateIssued>
   </mods:originInfo>
   <mods:identifier type="uri">https://hdl.handle.net/10630/25713</mods:identifier>
   <mods:abstract>There are many Immunotherapy methods in ovarian cancer. Even the immune cells themselves can be part of the immunotherapy. But also at molecular level, the immunotherapy can be applied, like maintaining damage in DNA or inhibiting certain pathways. Nevertheless, there is still needed to understand the mechanism of immunotherapy.</mods:abstract>
   <mods:language>
      <mods:languageTerm>eng</mods:languageTerm>
   </mods:language>
   <mods:accessCondition type="useAndReproduction">http://creativecommons.org/licenses/by-nc-nd/4.0/</mods:accessCondition>
   <mods:accessCondition type="useAndReproduction">open access</mods:accessCondition>
   <mods:accessCondition type="useAndReproduction">Attribution-NonCommercial-NoDerivatives 4.0 Internacional</mods:accessCondition>
   <mods:subject>
      <mods:topic>Inmunoterapia - Congresos</mods:topic>
   </mods:subject>
   <mods:subject>
      <mods:topic>Cancer - Congresos</mods:topic>
   </mods:subject>
   <mods:titleInfo>
      <mods:title>Analysis of Immunotherapy in ovarian cancer</mods:title>
   </mods:titleInfo>
   <mods:genre>conference output</mods:genre>
</mods:mods>
</metadata></record></GetRecord></OAI-PMH>